Analyst Consensus ?
ConsensusBuy32 ratings
Bullish2062.5%
Neutral928.1%
Bearish39.4%
PTC Inc. · PTC · FY2026 Q1 · Calendar Q1 2026
PTC raises FY2026 outlook as ARR growth and AI roadmap advance
PTC’s latest results support a constructive operating narrative: ARR and free cash flow grew, management raised FY2026 revenue and non-GAAP EPS guidance, and deferred ARR plus embedded AI are central to the growth plan. The key test is whether deferred demand converts into recognized ARR while AI releases and cross-sell efforts produce durable growth.
Reported After market closeNASDAQTechnology
$15.89B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$1.92
Consensus $1.59
EPS surprise
+20.8%
Reported versus consensus
Reported revenue
$685.8M
Consensus $639.0M
Revenue surprise
+7.3%
Reported versus consensus
Market reaction
event-close to next-session close
Stock move
+1.7%
Event window
SPY move
-1.2%
Same window
Abnormal move
+3.0%
Stock minus SPY
Volume
2.6×
Versus trailing sessions
Subsequent drift
+5.7%
Up to 20 sessions
PTCSPY benchmark
Ask FN2 about PTC FY2026 Q1
Transcript, numbers and history already loaded
Why did PTC rise 1.7% after beating EPS estimates in FY2026 Q1?What changed in PTC's guidance and outlook in FY2026 Q1?Give me the bull and bear case for PTC after FY2026 Q1 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior-quarter analysis, the outlook moved from maintained to raised guidance. ARR growth was reported at 9% in constant currency, free cash flow growth at 13%, and the company emphasized broader embedded-AI releases, SaaS Plus expansion and a larger FY2026 repurchase program.
Guidance delta
FY2026 revenue and non-GAAP EPS guidance were raised.
Key takeaways
- ARR grew 9% year over year in constant currency and free cash flow rose 13%.
- AI functionality is being embedded across Creo, Windchill, CodeBeamer and ServiceMax.
- Record deferred ARR and strategic cross-product deals support management’s multiyear growth narrative.
- The FY2026 share-repurchase program was set at $1.1–$1.3 billion.
- Management highlighted SaaS Plus expansion, cloud-first migrations and vertical wins in automotive, aerospace and industrial manufacturing.
Management priorities
- Advance AI functionality across the product portfolio.
- Scale SaaS Plus offerings and cloud-first customer migrations.
- Continue roadmap releases for Creo, Windchill and ServiceMax.
- Complete the Kepware and ThingWorx divestiture and allocate proceeds to share repurchases.
- Sustain cross-product demand capture and go-to-market execution.
Follow PTC with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$140.04Current
$120Low
$172.65Average
$255High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 30, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Citigroup | Neutral | Neutral | Maintain | Jul 31, 2026 |
| Stifel | Buy | Buy | Maintain | Jul 30, 2026 |
| Rosenblatt | Buy | Buy | Maintain | Jul 30, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Jul 30, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 30, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Mar 23, 2026 |
| Keybanc | Overweight | Overweight | Maintain | Mar 17, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Feb 5, 2026 |
| JP Morgan | Underweight | Neutral | Downgrade | Feb 2, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Jan 28, 2026 |
| Baird | Outperform | Outperform | Maintain | May 1, 2025 |
| BMO Capital | Outperform | Outperform | Maintain | Aug 1, 2024 |
| Loop Capital | Buy | Buy | Maintain | Feb 2, 2023 |
| Berenberg | Buy | Buy | Maintain | Jan 11, 2023 |
| Wolfe Research | Outperform | Outperform | Maintain | Aug 17, 2022 |
| Needham | Buy | Buy | Maintain | Dec 16, 2020 |
| Credit Suisse | Neutral | Neutral | Maintain | Oct 30, 2020 |
| Wedbush | Neutral | Neutral | Maintain | Jan 23, 2020 |
| Stifel Nicolaus | Hold | Hold | Maintain | Jan 23, 2020 |
| Guggenheim | Neutral | Buy | Downgrade | Jul 25, 2019 |
| Deutsche Bank | Buy | Buy | Maintain | Apr 25, 2019 |
| Bank of America | Underperform | Neutral | Downgrade | Apr 25, 2019 |
| B of A Securities | Underperform | Neutral | Downgrade | Apr 25, 2019 |
| Cowen & Co. | Outperform | Outperform | Maintain | Jul 9, 2018 |
| Goldman Sachs | Neutral | Neutral | Maintain | Jul 17, 2017 |
| Benchmark | Buy | Buy | Maintain | May 18, 2017 |
| Brean Capital | Buy | Buy | Maintain | Oct 7, 2016 |
| CLSA | Outperform | Outperform | Maintain | Oct 4, 2016 |
| Evercore ISI Group | Buy | Buy | Maintain | Sep 15, 2016 |
| Sterne Agee CRT | Buy | Neutral | Upgrade | Feb 1, 2016 |
| Sterne Agee | Buy | Neutral | Upgrade | Feb 1, 2016 |
| Mitsubishi UFJ | Neutral | Neutral | Maintain | Jan 13, 2016 |
Named analyst price targets
Upside is calculated against the persisted current price $140.04. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Stifel Nicolaus | Analyst unavailable | $165 | $132.46 | +17.8% | Jul 30, 2026 |
| Piper Sandler | Analyst unavailable | $157 | $132.46 | +12.1% | Jul 30, 2026 |
| Barclays | Saket Kalia | $155 | $132.46 | +10.7% | Jul 30, 2026 |
| BMO Capital | Daniel Jester | $164 | $132.46 | +17.1% | Jul 30, 2026 |
| BMO Capital | Analyst unavailable | $155 | $115.56 | +10.7% | Jul 24, 2026 |
| Barclays | Analyst unavailable | $150 | $124.74 | +7.1% | Jul 13, 2026 |
| BNP Paribas | Analyst unavailable | $130 | $116.94 | -7.2% | Jun 18, 2026 |
| Berenberg Bank | Analyst unavailable | $170 | $144.88 | +21.4% | May 27, 2026 |
| Robert W. Baird | Analyst unavailable | $198 | $136.76 | +41.4% | May 7, 2026 |
| Barclays | Analyst unavailable | $185 | $136.76 | +32.1% | May 7, 2026 |
| Stifel Nicolaus | Analyst unavailable | $180 | $157.24 | +28.5% | Feb 5, 2026 |
| RBC Capital | Analyst unavailable | $195 | $155.98 | +39.2% | Feb 5, 2026 |
| BMO Capital | Daniel Jester | $189 | $151.34 | +35.0% | Feb 5, 2026 |
| KeyBanc | Analyst unavailable | $210 | $151.34 | +50.0% | Feb 5, 2026 |
| Oppenheimer | Analyst unavailable | $200 | $164.63 | +42.8% | Jan 28, 2026 |
| Robert W. Baird | Joe Vruwink | $255 | $204.55 | +82.1% | Oct 22, 2025 |
| KeyBanc | Analyst unavailable | $245 | $202.51 | +75.0% | Jul 31, 2025 |
| Barclays | Saket Kalia | $233 | $202.51 | +66.4% | Jul 31, 2025 |
| Cantor Fitzgerald | Kristen Kluska | $120 | $202.63 | -14.3% | Jul 29, 2025 |
| Piper Sandler | Clarke Jeffries | $180 | $156.34 | +28.5% | May 1, 2025 |
| Robert W. Baird | Analyst unavailable | $185 | $143.81 | +32.1% | Apr 22, 2025 |
| KeyBanc | Jason Celino | $185 | $143.98 | +32.1% | Apr 16, 2025 |
| Barclays | Saket Kalia | $175 | $146.54 | +25.0% | Apr 14, 2025 |
| Robert W. Baird | Joe Vruwink | $228 | $189.1 | +62.8% | Nov 7, 2024 |
| Robert W. Baird | Joe Vruwink | $226 | $184.81 | +61.4% | Oct 22, 2024 |
| BMO Capital | Daniel Jester | $206 | $185.5 | +47.1% | Oct 15, 2024 |
| Loop Capital Markets | Yun Kim | $220 | $181 | +57.1% | Oct 14, 2024 |
| Mizuho Securities | Siti Panigrahi | $190 | $174.11 | +35.7% | Jun 4, 2024 |
| Oppenheimer | Ken Wong | $165 | $137.85 | +17.8% | Oct 30, 2023 |
| Loop Capital Markets | Daniel Jester | $166 | $130.08 | +18.5% | May 24, 2023 |
| Berenberg Bank | Analyst unavailable | $155 | $127.4 | +10.7% | Jan 11, 2023 |
| Barclays | Analyst unavailable | $120 | $114.55 | -14.3% | Apr 28, 2022 |
| Mizuho Securities | Analyst unavailable | $135 | $110.6 | -3.6% | Apr 28, 2022 |
| RBC Capital | Analyst unavailable | $130 | $99.12 | -7.2% | Apr 25, 2022 |
| Loop Capital Markets | Yun Kim | $160 | $122.37 | +14.3% | Nov 9, 2021 |
| Griffin | Jay Vleeschhouwer | $156 | $126.43 | +11.4% | Nov 8, 2021 |
| Barclays | Saket Kalia | $141 | $120.93 | +0.7% | Nov 4, 2021 |
| Deutsche Bank | Johannes Schaller CFA | $150 | $119.87 | +7.1% | Oct 5, 2021 |
Track every rating change on PTC the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationPTC Inc. operates as a global provider of software and services, with its market presence extending across the Americas, Europe, and the Asia Pacific regions. The company's business is organized into two primary divisions: Software Products and Professional Services. Among its key offerings is the ThingWorx platform, which furnishes enterprises with a suite of functionalities to drive digital innovation across their operations. These solutions are characterized by ease of creation and deployment, scalability for future demands, and their ability to accelerate value realization for customers. Another significant product, Vuforia, enables the visualization of digital information within real-world contexts and facilitates the development of augmented reality applications.…
Historical context
All PTC earningsTechnology peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| SNX TD Synnex Corp | FY2026 Q3 · Calendar Q3 2026 | +20.9% | -9.9% | TD SYNNEX: AI-led growth accelerates, but mix and cash flow matter |
| ADBE Adobe Inc. | FY2026 Q3 · Calendar Q3 2026 | +0.8% | +1.4% | Adobe raises FY26 outlook as AI strategy broadens |
| ORCL Oracle Corporation | FY2027 Q1 · Calendar Q3 2026 | +10.3% | -1.7% | Oracle raises FY27 outlook as AI demand accelerates cloud growth |
| SAIL SailPoint, Inc. | FY2027 Q2 · Calendar Q3 2026 | +13.8% | -1.2% | SailPoint pairs 25% ARR growth with accelerating AI-driven adoption |
| CIEN Ciena Corporation | FY2026 Q3 · Calendar Q3 2026 | +22.0% | -10.4% | Ciena raises outlook as AI networking demand lifts backlog |
| DOCU DocuSign, Inc. | FY2027 Q2 · Calendar Q3 2026 | +6.4% | +3.7% | DocuSign Q2 FY27: IAM momentum supports a raised outlook |
Latest beats and misses
Who reports nextBeat on EPS
- CCLFY2026 Q3 · September 29, 2026+5.9% EPS+13.4% move
- COSTFY2026 Q4 · September 24, 2026+3.2% EPS+2.9% move
- SNXFY2026 Q3 · September 24, 2026+20.9% EPS-9.9% move
- DRIFY2027 Q1 · September 24, 20260.0% EPS-3.0% move
- CTASFY2027 Q1 · September 23, 2026+3.0% EPS-3.4% move
- PAYXFY2027 Q1 · September 23, 2026+1.5% EPS-8.8% move
Get the PTC recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-09-30T15:56:11.778199+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-30T15:56:11.775412+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-09-30. For educational purposes only; not investment advice.